c.correia
TL2 · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 15 April 2025 · last posted 20h
80 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #102 · Lounge › Introductions · 27 Jul 2026 · 18 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #125 · Sourcing › Independent verification · 26 Jul 2026 · 2 likes Second-hand on Interpreting a result, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #65 · Sourcing › Regulatory · 24 Jul 2026 · 9 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #49 · Pharmacology › Receptor biology · 19 Jul 2026 · 22 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #100 · Sourcing › Independent verification · 17 Jul 2026 · 18 likes Helpful, and short, which on this subject is harder than long.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #44 · Evidence › Journal club · 10 Jul 2026 · 0 likes Everything in post #40 holds. The case it does not cover is the one I have. The figures usually contain the finding and the text usually contains the interpretation.…
-
Does a peptide degrade silently, with no visual change? Replied, post #59 · Practice › Storage & stability · 30 Jun 2026 · 26 likes Reframing peptide slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #64 · Analytics › Method validation · 23 Jun 2026 · 0 likes Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The chromatograms from that work are more informative than…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #12 · Access › Shortages · 12 Jun 2026 · 22 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. This has been discussed before…
-
Follow-up: Search filters: what is missing Replied, post #125 · Meta › Site feedback · 10 Jun 2026 · 0 likes Search filters: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #27 · Practice › Storage & stability · 3 Jun 2026 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #76 · Sourcing › Vendor reports · 31 May 2026 · 16 likes Narrowing post #75, because the general version has more than one answer. The cost of a submission is worth stating. It is the main reason people do not do this and…
-
Run-in periods and the population they select Replied, post #126 · Evidence › Trials · 29 May 2026 · 2 likes Narrowing post #125, because the general version has more than one answer. Nothing in a trial report is medical advice about an individual, and the gap between a…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #3 · Start Here › Welcome · 14 May 2026 · 32 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #35 · Practice › Dosing & titration · 11 May 2026 · 1 like I would rather this thread reach "we do not know" about Micro-titration than reach a confident answer that nobody can support when asked.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #12 · Practice › Reconstitution · 7 May 2026 · 0 likes Post #11 is right about the mechanism and I think understates the practical bit. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
The best-written scientific paper you have read Replied, post #32 · Lounge › Off topic · 5 May 2026 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Blind submission and why it changes minds — the long version Replied, post #36 · Sourcing › Independent verification · 22 Apr 2026 · 0 likes Adding a reference point for Blind submission. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
A single out-of-range value on an otherwise normal panel Replied, post #37 · Clinical › Bloodwork · 21 Apr 2026 · 11 likes The documentation on single out-of-range value is better than this thread and I say that as someone who has posted in the thread.
-
System suitability injections: if they failed, the run did not happen — the long version Replied, post #2 · Analytics › HPLC & UHPLC · 11 Apr 2026 · 19 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #35 · Clinical › Bloodwork · 9 Apr 2026 · 2 likes Taking post #33 at face value and following it one step further. The question underneath Thyroid function tests during substantial is usually "how would I tell?" rather…
-
A parcel stationary at a customs facility for nine days Replied, post #46 · Sourcing › Logistics · 7 Apr 2026 · 0 likes Thank you — that answers what I came here to find out.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #61 · Research Methods › Statistics · 25 Mar 2026 · 0 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. Worth saying I have only…
-
Coming back to: Time to steady state after a dose increase Replied, post #19 · Pharmacology › Pharmacokinetics · 23 Mar 2026 · 9 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. The…
-
Micro-titration: a disputed topic, argued properly Replied, post #49 · Practice › Dosing & titration · 21 Mar 2026 · 10 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #11 · Practice › Side effects · 19 Mar 2026 · 6 likes Gastrointestinal effects in this class are dose-related and escalation-related. Both are true simultaneously, which is why symptoms typically return at each step and…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #2 · Nutrition & Training › Protein & intake · 13 Mar 2026 · 0 likes Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth applying to your own numbers. The interesting part of this is the…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #65 · Practice › Interactions · 12 Mar 2026 · 26 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Second pass at: What pooling buys you and what it destroys Replied, post #26 · Evidence › Meta-analyses · 11 Mar 2026 · 0 likes Post #24 and I disagree about the size of the effect, not about the direction. Study quality and weighting: some meta-analyses weight all studies equally; others weight…
-
Coming back to: Training through a dose escalation week Replied, post #47 · Nutrition & Training › Resistance training · 9 Mar 2026 · 12 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
The lowest dose that does anything: is that a real question? Replied, post #12 · Practice › Dosing & titration · 1 Mar 2026 · 9 likes The reason lowest dose keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Second pass at: Identical chromatograms across two different lots Replied, post #15 · Sourcing › Red flags · 19 Feb 2026 · 13 likes Reporting something here requires the batch, the date, the method and the document, which is exactly what makes the reports worth reading two years later. If anyone has…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #122 · Sourcing › Independent verification · 14 Feb 2026 · 29 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #7 · Compounds › Tirzepatide · 4 Feb 2026 · 4 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Filter needles: when they help and what they cost you Replied, post #39 · Devices › Syringes & needles · 30 Jan 2026 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #2 · Start Here › Welcome · 13 Jan 2026 · 9 likes No notes. Posting so the count is not one.
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #26 · Practice › Side effects · 10 Jan 2026 · 5 likes Taking nausea timeline seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #14 · Practice › Side effects · 26 Dec 2025 · 12 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Airline travel with a temperature-sensitive injectable Replied, post #23 · Devices › Cold chain · 17 Dec 2025 · 20 likes Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive cool. Checking on arrival that cold packs are still…
-
Follow-up: A supplier that answers analytical questions with restated claims Started this topic · Sourcing › Red flags · 25 Nov 2025 · 5 likes A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable. A follow-up question about…
-
Second pass at: Programming during a large energy deficit Replied, post #78 · Nutrition & Training › Resistance training · 12 Nov 2025 · 19 likes The arithmetic in post #77 is right; the assumption feeding it is the part to check. Taking Programming during a large energy seriously for a moment rather than…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #9 · Compounds › Tirzepatide · 6 Nov 2025 · 0 likes Reading back through the tirzepatide titration schedules threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #2 · Access › Pricing · 18 Oct 2025 · 1 like Taking Price changes seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
Compounds this community declines to help with, and why Replied, post #52 · Compounds › Other compounds · 3 Oct 2025 · 10 likes Where I part company with post #50, and it is a narrow parting. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
-
Pooling trials with different estimands — what changed since Replied, post #32 · Evidence › Meta-analyses · 3 Oct 2025 · 32 likes I had written a reply contradicting post #28 and deleted it. Here is what survived. If you are new and reading this thread for the answer to Pooling trials with…
-
A preprint whose numbers changed substantially at publication Replied, post #76 · Evidence › Preprints · 3 Oct 2025 · 23 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. I would rather be…
-
Request: a diff view for wiki revisions — the long version Replied, post #37 · Meta › Feature requests · 1 Sep 2025 · 10 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. Same conclusion as the reply above, reached differently,…
-
Hepatic impairment and the absence of data Replied, post #8 · Clinical › Special populations · 7 Aug 2025 · 21 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Reading SURMOUNT-1 without the press release — one year on Started this topic · Compounds › Tirzepatide · 31 Jul 2025 · 21 likes Reading SURMOUNT-1 without the press release — one year on — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with…
-
How to read a forest plot, properly, from scratch Replied, post #9 · Evidence › Trials · 26 Jul 2025 · 10 likes Post #8 describes the usual case. This is about the unusual one. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who…
-
Canadian access and provincial variation — one year on Replied, post #17 · Regional › North America · 22 Jul 2025 · 0 likes The most useful thing anyone has posted about Canadian access and provincial variation in this category was a table of what had been measured and by whom. That is what…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #82 · Compounds › Retatrutide · 20 Jul 2025 · 2 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #26 · Start Here › How to Ask · 17 Jul 2025 · 3 likes Helpful, and short, which on this subject is harder than long.
-
Insulin combinations and hypoglycaemia risk Replied, post #17 · Practice › Interactions · 22 Jun 2025 · 0 likes I read the earlier replies on insulin combinations and hypoglycaemia risk twice before writing this, because I had assumed the opposite and wanted to be sure I was…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #11 · Compounds › Retatrutide · 12 Jun 2025 · 31 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
-
Follow-up: What other technical communities get right that we do not Replied, post #124 · Lounge › Off topic · 8 Jun 2025 · 3 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #35 · Nutrition & Training › Protein & intake · 7 Jun 2025 · 19 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #17 · Nutrition & Training › Hydration & electrolytes · 28 May 2025 · 14 likes Post #13 describes the usual case. This is about the unusual one. The most useful posts here describe what was measured, what was changed, and what happened, in that…
-
Retatrutide dose escalation in the published trials Replied, post #103 · Compounds › Retatrutide · 8 Apr 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #39 · Sourcing › Vendor reports · 30 Mar 2025 · 1 like Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That much is documented. The rest is how I have…
-
Charge states for a 4 kDa peptide, worked through Replied, post #20 · Analytics › Mass spectrometry · 4 Mar 2025 · 13 likes Building on post #19 rather than restating it. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the…
-
Consistent declarations and why they matter more than clever ones Replied, post #89 · Sourcing › Logistics · 26 Feb 2025 · 7 likes That is consistent with mine, for whatever one more account is worth.
-
Requesting a page: what makes a good request Replied, post #7 · Documentation › Wiki requests · 24 Feb 2025 · 3 likes On post #5 — agreed on the reasoning, with one qualification. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues,…
-
Coming back to: Official shortage notices and what they authorise Replied, post #11 · Access › Shortages · 10 Feb 2025 · 0 likes This follows post #8 rather than contradicting it. Worth separating Official shortage notices as a question about the compound from Official shortage notices as a…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #49 · Analytics › Mass spectrometry · 6 Feb 2025 · 0 likes Trying to state the mass spectrometry position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #38 · Clinical › Bloodwork · 31 Jan 2025 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Time of day: some biomarkers vary across the day. Cortisol in the morning differs…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #44 · Wellbeing › Mental health · 30 Jan 2025 · 32 likes Where I part company with post #40, and it is a narrow parting. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
-
Reading a supplementary appendix and finding the interesting part Replied, post #69 · Evidence › Trials · 16 Jan 2025 · 32 likes Something worth flagging about reading a supplementary appendix: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
How compounding permissions changed when supply normalised Replied, post #3 · Sourcing › Regulatory · 25 Dec 2024 · 9 likes Understood, and I withdraw the assumption I opened with.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #36 · Compounds › Other compounds · 9 Dec 2024 · 0 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
-
What a seizure notice actually says Replied, post #13 · Sourcing › Logistics · 4 Dec 2024 · 0 likes Offering a way to settle seizure notice rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
When "no data" is the complete and final answer Replied, post #31 · Compounds › Other compounds · 30 Nov 2024 · 31 likes Second this, and I would have said it less carefully.
-
Fixed versus detachable needles: the trade-offs Replied, post #22 · Devices › Syringes & needles · 27 Nov 2024 · 0 likes Fixed versus detachable needles would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #79 · Compounds › Repair & healing peptides · 17 Nov 2024 · 17 likes I read post #77 twice before replying, because I had assumed the opposite. On reading a preclinical wound-healing model I would separate what is worth knowing from what…
-
EMA product information as a primary source — does this still hold? Started this topic · Regional › European Union · 14 Nov 2024 · 5 likes The question in the title: EMA product information as a primary source — does this still hold? I will give what I have already checked below so nobody repeats it.…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #7 · Practice › Reconstitution · 6 Nov 2024 · 15 likes Post #6 is the version of this I will quote in future. One addition. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #2 · Sourcing › Regulatory · 5 Oct 2024 · 2 likes Narrowing the opening post, because the general version has more than one answer. My position on Research-use-only labelling is current rather than settled. I have…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #54 · Evidence › Journal club · 25 Sep 2024 · 5 likes Post #52 is right about the mechanism and I think understates the practical bit. One more thing on SURPASS-2 that took me far too long to see: the two figures people…
-
Correlation in a self-tracked dataset: what it can support Replied, post #77 · Research Methods › Statistics · 23 Aug 2024 · 2 likes Narrowing post #74, because the general version has more than one answer. Effect sizes: the magnitude of a difference, not just whether it is statistically significant.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #92 · Sourcing › Logistics · 1 Jun 2024 · 2 likes The reason Assessing a warm arrival is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…